Contact Information
Company Information
Company
AUROBAC THERAPEUTICS
Professional Summary
Florence Sejourne serves as Chief Executive Officer at AUROBAC THERAPEUTICS. AUROBAC THERAPEUTICS operates in the biotechnology sector with approximately 29.0 employees. The company is headquartered in Paris, Ile-de-France.
Industry & Role Insights
-
•
MessageCEO tracks 381 executives in the biotechnology sector.
-
•
4,101 executive contacts are available in Ile-de-France.
-
•
Our database includes 201,464 c suite-level executives.
Technologies
Outlook
Microsoft Office 365
Apache
YouTube
WordPress.org
Mobile Friendly
Remote
AI
Keywords
biopharmaceutical
antimicrobial resistance
acute bacterial infections
critical care
hospital-acquired infections
ventilator-associated pneumonia
hospital-acquired pneumonia
sepsis
septic shock
diagnostic strategies
precision medicines
innovative treatment
patient stratification
treatment optimization
clinical trials
emerging pathogens
gram-negative bacteria
multi-drug resistance
antibiotic stewardship
therapeutic development
pathogen-targeted programs
r&d pipeline
biologics
new chemical entities
first-in-class drugs
healthcare-associated infections
diagnostic innovation
medical needs
clinical efficacy
novel antibiotics
synthetic peptides
infection prevention
drug discovery
collaborative research
healthcare economics
patient outcomes
acute respiratory infections
life-threatening infections
intensive care
nosocomial infections
economic burden
clinical microbiology
globally relevant pathogens
biomedical research
partnership opportunities
drug development strategy
preclinical studies
infectious diseases
bacterial pathogens
health care
health
wellness & fitness
hospital & health care
Related Executives
Outreach Guidance — biotechnology Sector
Technology executives make decisions on infrastructure, tooling, and partnerships. When reaching out to Florence Sejourne, lead with your value proposition relative to the stack they currently use. Generic pitches perform poorly; specific technical relevance is key.
Florence Sejourne's Position in the MessageCEO Database
- •Florence Sejourne is 1 of 1 verified executive contact we track at AUROBAC THERAPEUTICS.
- •365 verified executive contacts in biotechnology are in the MessageCEO database.
- •4,045 verified executive contacts in Ile-de-France are in the database.
- •10 verified contacts work at biotechnology companies in the 29.0 employee range (same size as AUROBAC THERAPEUTICS).
Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated November 2026.
Frequently Asked Questions
How do I reach Florence Sejourne directly?
Florence Sejourne's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Executive Officer at AUROBAC THERAPEUTICS. Access direct contact info to skip gatekeepers and reach the decision maker.
What company does Florence Sejourne work for?
Florence Sejourne is Chief Executive Officer at AUROBAC THERAPEUTICS, a company in the biotechnology sector with 29.0 employees. The company is based in Paris, Ile-de-France.
Can I pitch or sell to Florence Sejourne?
As Chief Executive Officer at AUROBAC THERAPEUTICS, Florence Sejourne is a key decision-maker in the biotechnology sector. MessageCEO Pro gives you verified email to reach Florence Sejourne directly — ideal for B2B sales, partnerships, and executive recruiting.
What industry is Florence Sejourne in?
Florence Sejourne works in the biotechnology industry as Chief Executive Officer at AUROBAC THERAPEUTICS. MessageCEO provides verified contact information for executives across all major industries.
Is Florence Sejourne's contact information verified?
Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Florence Sejourne's profile is kept up-to-date with the latest available information.
Last updated: November 10, 2026
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans